The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
S Oparil, S Dyke, F Harris, J Kief, D James, A Hester… - Clinical …, 1996 - Elsevier
A multicenter, randomized, placebo-controlled, double-masked, parallel-group study was
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
S Oparil, S Dyke, F Harris, J Kief, D James, A Hester… - Clinical …, 1996 - infona.pl
A multicenter, randomized, placebo-controlled, double-masked, parallel-group study was
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
[引用][C] The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
S OPARIL, S DYKE, F HARRIS, J KIEF… - Clinical …, 1996 - pascal-francis.inist.fr
The efficacy and safety of valsartan compared with placebo in the treatment of patients with
essential hypertension CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
essential hypertension CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
S Oparil, S Dyke, F Harris, J Kief… - Clinical …, 1996 - pubmed.ncbi.nlm.nih.gov
A multicenter, randomized, placebo-controlled, double-masked, parallel-group study was
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
[引用][C] The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
S OPARIL - Clin Ther, 1996 - cir.nii.ac.jp
The efficacy and safety of valsartan compared with placebo in the treatment of patients with
essential hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
essential hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension.
S Oparil, S Dyke, F Harris, J Kief, D James… - Clinical …, 1996 - europepmc.org
A multicenter, randomized, placebo-controlled, double-masked, parallel-group study was
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
S Oparil, S Dyke, F Harris, J Kief… - Clinical …, 1996 - clinicaltherapeutics.com
A multicenter, randomized, placebo-controlled, double-masked, parallel-group study was
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
performed to compare the efficacy and safety of valsartan 20, 80, 160, and 320 mg with …
[引用][C] The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
S Oparil, S Dyke, F Harris, J Kief, D James… - Clinical …, 1996 - cir.nii.ac.jp
The efficacy and safety of valsartan compared with placebo in the treatment of patients with
essential hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …
essential hypertension | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] …